Article
Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
Folia microbiologica - 1 Sept 2017
Savari Mohammad, Ekrami Alireza, Shoja Saeed, Bahador Abbas
Abstract excerpt
Colistin is the last hope to treat extensively drug resistance (XDR) Acinetobacter baumannii (A. baumannii) infections, but resistance to colistin is currently reported in clinical centers all over the world. Here, we studied two colistin-resistant A. baumannii isolates with a difference in minimum inhibitory concentrations (MICs) that were isolated from a single burn patient during treatment in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
